OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection
Yun Hu, Sébastien Paris, Narayan Sahoo, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 11

Showing 11 citing articles:

The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 9

Cutting-Edge Therapies for Lung Cancer
Anita Silas La’ah, Shih‐Hwa Chiou
Cells (2024) Vol. 13, Iss. 5, pp. 436-436
Open Access | Times Cited: 9

Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization
Jordan Da Silva, Célia Bienassis, Peter Schmitt, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4

Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Zhijie Xu, Zhiyang Zhou, Xiaoxin Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Application of nano-radiosensitizers in non-small cell lung cancer
Xiao Hu, Jiamiao Hu, Yueyue Pang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2

Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors
Kexin Meng, Haijun Lu
Precision Radiation Oncology (2024) Vol. 8, Iss. 1, pp. 42-46
Open Access | Times Cited: 1

Understanding the Role of Radio-Sensitizing Nanoparticles in Enhancing Pathologic Response in Soft Tissue Sarcomas
Anastasia Stergioula, E. Pantelis, Vasileios Kontogeorgakos, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5572-5572
Open Access | Times Cited: 3

Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy
Yun Hu, Alexey S. Revenko, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access

Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3
Yun Hu, Sébastien Paris, Narayan Sahoo, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access

Advancing cancer immunotherapy through emerging intratumoral delivery and biomedical imaging technologies
Eun-Seo Choi, Alexander F. Bagley, Sakib Haque, et al.
Materials Today Advances (2024) Vol. 24, pp. 100539-100539
Closed Access

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 th immunorad conference
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
OncoImmunology (2024) Vol. 14, Iss. 1
Open Access

Page 1

Scroll to top